135 related articles for article (PubMed ID: 16755292)
1. Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours.
Uccini S; Colarossi C; Scarpino S; Boldrini R; Natali PG; Nicotra MR; Perla FM; Mannarino O; Altavista P; Boglino C; Cappelli CA; Cozzi D; Donfrancesco A; Kokai G; Losty PD; McDowell HP; Dominici C
Br J Cancer; 2006 Jul; 95(1):49-55. PubMed ID: 16755292
[TBL] [Abstract][Full Text] [Related]
2. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
3. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
Ekmekci S; Olgun N; Özer E
Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
[TBL] [Abstract][Full Text] [Related]
6. VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours.
Ramani P; Nash R; Radevsky L; Patel A; Luckett M; Rogers C
Histopathology; 2012 Dec; 61(6):1006-16. PubMed ID: 22804730
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 Index as a Surrogate for Mitosis-Karyorrhexis Index in Neuroblastoma.
Atikankul T; Atikankul Y; Santisukwongchote S; Marrano P; Shuangshoti S; Thorner PS
Am J Surg Pathol; 2015 Aug; 39(8):1054-60. PubMed ID: 26171918
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
[TBL] [Abstract][Full Text] [Related]
9. Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group.
Joshi VV; Rao PV; Cantor AB; Altshuler G; Shuster JJ; Castleberry RP
Cancer; 1996 Apr; 77(8):1582-8. PubMed ID: 8608547
[TBL] [Abstract][Full Text] [Related]
10. GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours.
Ramani P; Headford A; May MT
Virchows Arch; 2013 Feb; 462(2):203-9. PubMed ID: 23307190
[TBL] [Abstract][Full Text] [Related]
11. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
[TBL] [Abstract][Full Text] [Related]
13. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
14. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
15. Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma.
Ramani P; Nash R; Rogers CA
Histopathology; 2015 Feb; 66(3):370-9. PubMed ID: 25297850
[TBL] [Abstract][Full Text] [Related]
16. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
[TBL] [Abstract][Full Text] [Related]
18. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
[TBL] [Abstract][Full Text] [Related]
20. Tumor histology during induction therapy in patients with high-risk neuroblastoma.
George RE; Perez-Atayde AR; Yao X; London WB; Shamberger RC; Neuberg D; Diller L
Pediatr Blood Cancer; 2012 Sep; 59(3):506-10. PubMed ID: 22162143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]